What can we help you with today?
Filter by Topics
Filter by Category
Found 1124 results
Workspan Daily Plus+
07/01/2025
Save
Reuse Permission
The decision to cover glucagon-like peptide-1 (GLP-1) drugs, such as Ozempic and Wegovy, on a group health plan is a complex one.
Author(s):
Workspan Daily
07/01/2025
Save
Reuse Permission
Glucagon-like peptide-1 (GLP-1) medications are more top-of-mind than ever this year for employees — and they’re looking to their employers to help pay for them.
Author(s):
Workspan Daily
11/15/2024
Toward the HCE exemption, the DOL’s 2024 rule stipulated that classified workers make at least: $132,964 in total annual compensation on July 1 (up from the previous $107,432 outlined in the 2019 final rule), and;$151,164 on Jan. 1, 2025.; In effect, the Nov. 15 court decision: Nullified the Jan. 1 threshold increases;;Rescinded the July 1 increases;;Eliminated another increase slated for July 1, 2027; and,;Nixed the DOLrule’s automatic “escalator” provision, which would have increased the thresholds every three years going forward, starting with the July 1, 2027, compliance date.;
The 2019 thresholds of $35,568 for the EAP exemption and $107,432 for the HCE exemption — both set by the DOL under the first Trump administration — are poised to go back into effect, according to reports .
Author(s):
Workspan Daily
10/14/2025
“Given the durability of hybrid work models across the workforce, the question most organizations should be focused on is how they can make their hybrid model work best for them,” Wigert said.
Author(s):
Tools
Total Rewards Model: A Guide
Learn what makes up Total Rewards and how it fits with an organization’s broader HR strategy.
Webinar
05/28/2025
Using the ADDIE model, this webinar offers a clear framework for building a benefits strategy that’s equitable, efficient, and future-focused.
Journal Article
08/23/2024
Public Relations Journal 9(1):1-23.
Author(s):
Workspan Daily Plus+
09/23/2025
Save
Reuse Permission
In traditional pharmacy benefit models, pharmacy benefit managers (PBMs) operate as a nontransparent intermediary, making it difficult for employers to see the true cost of medications or how rebates and discounts are managed.
Author(s):
Journal Article
06/11/2021
All models rely on the consistent set of drivers described earlier.
Author(s):
Workspan Daily
11/28/2025
Direct-to-Employer Model for Obesity Management Meds Announced
Waltz Health, a digital health company headquartered in Chicago, recently announced it will launch a direct-to-employer access model for
obesity management medicines approved by the U.S.
Author(s):